Patent details
EP1404323 Title: USE OF METHYLNALTREXONE TO TREAT IMMUNE SUPPRESSION
Basic Information
- Publication number:
- EP1404323
- PCT Application Number:
- PCT/US/2002/018087
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027418995
- PCT Publication Number:
- WO/2002/098422
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF METHYLNALTREXONE TO TREAT IMMUNE SUPPRESSION
- French Title of Invention:
- UTILISATION DE LA METHYLNALTREXONE POUR LE TRAITEMENT DE L'IMMUNODEPRESSION
- German Title of Invention:
- VERWENDUNG VON METHYLNALTREXON ZUR BEHANDLUNG VON IMMUNSUPPRESSION
- SPC Number:
Dates
- Filing date:
- 05/06/2002
- Grant date:
- 28/10/2009
- EP Publication Date:
- 28/10/2009
- PCT Publication Date:
- 12/12/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/04/2004
- EP B1 Publication Date:
- 28/10/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/06/2010
- Expiration date:
- 05/06/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/06/2002
- Name:
- The University of Chicago
- Address:
- 5640 South Ellis Avenue, Suite 405, Chicago, IL 60637, United States (US)
Inventor
1
- Name:
- MOSS Jonathan
- Address:
- United States (US)
2
- Name:
- YUAN Chun-Su
- Address:
- United States (US)
Priority
1
- Priority Number:
- 295571 P
- Priority Date:
- 05/06/2001
- Priority Country:
- United States (US)
2
- Priority Number:
- 374454 P
- Priority Date:
- 22/04/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/44;
| Filing date | Document type | Number of pages |
|---|